Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.

Abeykoon, Jithma P; Zanwar, Saurabh; Ansell, Stephen M; Gertz, Morie A; Kumar, Shaji; Manske, Michelle; Novak, Anne J; King, Rebecca; Greipp, Patricia; Go, Ronald; Inwards, David; Muchtar, Eli; Habermann, Thomas; Witzig, Thomas E; Thompson, Carrie A; Dingli, David; Lacy, Martha Q; Leung, Nelson; Dispenzieri, Angela; Gonsalves, Wilson; Warsame, Rahma; Kyle, Robert A; Rajkumar, Vincent; Parikh, Sameer A; Kapoor, Prashant.
Br J Haematol; 2019 Aug 29.
Artigo em Inglês | MEDLINE | ID: mdl-31468508

Não foram localizados documentos relacionados